MTIA is becoming quite the player in the new Echo story. Per the recent 10-K, they already own 7.6% of ECTE Medical Technologies Innovation Asia LTD..
872,728 (3) 7.6
Dr. Mike Goldberg was the one who brought MTIA to the table, culminating in the agreement reached in December, 2013. MTIA was to be the distributor in the Far East, and was initially supposed to invest $5 million into Echo, in exchange for stock and warrants. MTIA did invest $2.4 million under that agreement, but the old management team didn't deliver the promised stock and options, and the proxy battle was also making MTIA very nervous. So they ceased any additional investment until the management was changed. Eventually MTIA was given 872,728 shares of stock and 87,274 warrants for their first $2.4 million investment. After the Three #$%$ were thrown out, and the new management team was brought aboard, Dr. Goldberg was able to reestablish the relationship with MTIA and bring them back. MTIA then agreed to provide 40% of the latest $4 million financing.The investors in this latest financing, including MTIA, have provided $2.5 million of the $4 million they committed. The remaining $1.5 million is available at the discretion of Echo
Assuming Echo draws the remaining $1.5 million available to them, MTIA will then have a total of $4 million invested in ECTE. MTIA's involvement is not just as an investor and distributor. Their manufacturing connections and technical contacts are proving useful in the redesign of the Symphony system, and getting the manufacturing costs down from the original expectations. They're turning out to be a true partner.
MTIA is initiating the regulatory approval process this quarter with the China Food & Drug Administration (CFDA). They will bear the cost and responsibility of getting Symphony approved in that market. Upon approval Echo then receive 70% of the Net Sales up to $100 million, and Echo will receive 30%. After sales reach $100 million the split is 60% to MTIA and 40% to Echo.
Exactly my point, "impossible to predict" and the management continue to give the analysts anything to work with, a secret. Talked to one of the analysts and he's fed up with the "we can't disclose anything". Constant lowering of estimates doesn't help the stock price, IMO! We're in a vacuum!
Pre market $3.52 trades, gotta love the MM!
13mm? no way do you see that. Plus their quarterly numbers are all engineering on their part. Still no true product sales. Where are the deals he's promised you? That secondary he did at $3.75 will last maybe two quarters and we're already into the second one. Burn baby burn. Hire more talking heads with fat salaries to whose benefit? Shareholders? NO way. AS tries to control the CC with his blabbering but what do the analysts do every quarter, cut their numbers. They are left in the dark on what ever is going on at this shop. We'll see how he'll spin the next CC, can't wait.
China news? MTIA is simply meeting with the CFDA to begin the pathway for approval, that's all. Don't expect any other China news.
nothings changed.. the delayed 10K although was reasonable to assume was possible helped the short and weak longs push the stock. Now breaking down somewhat and still have (2) catalysts- Can CEO get us a partnership for the DATA/Wearable space? Not sure.. China FDA is the other and the initial meeting is scheduled for this quarter (Q2). Is it early or late Q2, no clue but any update on the progress from that and possible timeline should help. We wait..
philly you sound like a #$%$ off ex employee. If you had discussed anything at all with the company you would have known that it was possible the 10k would be filed late. Pretty good justifications, No? It's not a big deal considering it will be filed in 15 days. Keep on working the stock lower there Philly be glad to keep nibbling. Thanks Grieco!
Not sure why they would get specific on detail about product pricing info yet. If getting the IRB to sign off as you say is easy than it's easy, who cares. As far as addressing any other outstanding product problems like accuracy and or cost, this is what the Chinese are helping with and if you remember in their presentation, Q4 was when they said they'd have a "redesigned, lower cost system that includes flexible sensor and simplified abrader. Don't think we're in Q4 yet!
As far as 10K it'll be out and everyone who's in the stock knows it won't be pretty based on what the three lingering directors did to this company. Phillytobostonguy, are you related at all to any of the lingering three? Just curious.
This is nice to see but not a march higher event IMO. A partnership established or information on the China FDA play. RE: China, meeting is in Q2 and hopefully we'll get any update on the meeting and eventual timeline. As far as partnership(s), well that's anyone's guess. Can the new CEO ink a partnership with big Data/wearable company?
Two catalysts present itself, possible partnership re: Big Data/wearable space and the runway for ChinaFDA and the approval process. ChinaFDA meeting is slated for Q2 so hopefully we get something to chew on regarding the potential timeline there. As far as partnerships, it's anyone's guess at this point but hopefully we start getting some hints on a strong possibility for one.
No shares out there, very little float.
Holy #$%$ hondadriver! You can't be that rahtarded. Please just sell whatever you have in the market and put it under your mattress.
phillytoboston, let me start off by first saying I'm sorry you're short ECTE. What Platinum did was save this company and you have a problem with that, sounds like a short to me. The 500K loan was to keep the lights on and funded through the Goldbergs so the three idiots couldn't get their hands on it. Platinum took a big risk with this loan and the proxy expense and should be rewarded. Their plan worked and they got the idiots out, the idiots who basically stripped this company to nothing. Now we have a new management and a new business plan that will be revealed shortly I'm sure. Oh and you have a currency, ECTE stock, that has risen from $.50 when the three idiots were shutting the lights off. You might want to cover your short because there's basically zero stock in the system and when the new business plan is told I suspect the stock will continue on its upward trajectory. You've been warned!